Ab­b­Vie goes deep­er in­to neu­ro­science with col­lab­o­ra­tion worth as much as $2B

In its next big neu­ro deal, Ab­b­Vie is bet­ting $65 mil­lion — and an­oth­er $1.95 bil­lion in po­ten­tial pay­ments — on a plat­form that aims to achieve …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.